{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:51:34Z","timestamp":1764510694405},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,10]]},"DOI":"10.7759\/cureus.9114","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T13:40:50Z","timestamp":1594388450000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Valproate-Induced Hyperammonemic Encephalopathy"],"prefix":"10.7759","author":[{"given":"Faraaz","family":"Zafar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beau M","family":"Billadeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsen U","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302700510","article-title":"Valproate-induced coma: case report and literature review","volume":"27","author":"Duarte J","year":"1993","unstructured":"Duarte J, Macias S, Coria F, Fernandez E, Claver\u00eda LE. Valproate-induced coma: case report and literature review. Ann Pharmacother. 1993, 27:582-583. 10.1177\/106002809302700510","journal-title":"Ann Pharmacother"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2018.03.073","article-title":"Valproic acid-induced hyperammonemia: incidence, clinical significance, and treatment management","volume":"8","author":"Baddour E","year":"2018","unstructured":"Baddour E, Tewksbury A, Stauner N. Valproic acid-induced hyperammonemia: incidence, clinical significance, and treatment management. Ment Health Clin. 2018, 8:73-77. 10.9740\/mhc.2018.03.073","journal-title":"Ment Health Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2019.05.005","article-title":"Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions","volume":"59","author":"Duman B","year":"2019","unstructured":"Duman B, Can KC, A\u011fta\u015f-Ertan E, et al.. Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions. Gen Hosp Psychiatry. 2019, 59:67-72. 10.1016\/j.genhosppsych.2019.05.005","journal-title":"Gen Hosp Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik  Y","year":"2013","unstructured":"Ghodke-Puranik  Y, Thorn CF, Lamba JK, et al.. Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2013, 23:236-241. 10.1097\/FPC.0b013e32835ea0b2","journal-title":"Pharmacogenet Genomics"},{"key":"ref5","article-title":"Physiology, Urea Cycle","author":"Barmore W","year":"2020","unstructured":"Barmore W, Azad F, Stone WL. Physiology, Urea Cycle. StatPearls Publishing, Treasure Island, FL; 2020."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.11.031","article-title":"New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA","volume":"55","author":"Aires CCP","year":"2011","unstructured":"Aires CCP, Cruchten AV, Ijlst L, de Almeida IT, Duran M, Wanders RJA, Silva MFB. New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA. J Hepatol. 2011, 55:426-434. 10.1016\/j.jhep.2010.11.031","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-018-1666-3","article-title":"Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report","volume":"12","author":"Mehta S","year":"2018","unstructured":"Mehta S, Tayabali S, Lachmann R. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report. J Med Case Rep. 2018, 12:134. 10.1186\/s13256-018-1666-3","journal-title":"J Med Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1593","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"9","author":"Farooq F","year":"2017","unstructured":"Farooq F, Din JS, Khan AM, Naqvi S, Shagufta S, Mohit A. Valproate-induced hyperammonemic encephalopathy. Cureus. 2017, 9:e1593. 10.7759\/cureus.1593","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8512721","article-title":"Hyperammonemia: what urea-lly need to know: case report of severe noncirrhotic hyperammonemic encephalopathy and review of the literature","volume":"2016","author":"Upadhyay R","year":"2016","unstructured":"Upadhyay R, Bleck TP, Busl KM. Hyperammonemia: what urea-lly need to know: case report of severe noncirrhotic hyperammonemic encephalopathy and review of the literature. Case Rep Med. 2016, 2016:8512721. 10.1155\/2016\/8512721","journal-title":"Case Rep Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/35436-a-case-of-valproate-induced-hyperammonemic-encephalopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:22Z","timestamp":1707506362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/35436-a-case-of-valproate-induced-hyperammonemic-encephalopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.9114","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,10]]}}}